ATC Group: A07EA06 Budesonide

Position of A07EA06 in the ATC hierarchy

Level	Code	Title
1	A	Alimentary tract and metabolism
2	A07	Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3	A07E	Intestinal antiinflammatory agents
4	A07EA	Corticosteroids acting locally
5	A07EA06	Budesonide

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	9 mg

Active ingredients in A07EA06

Active Ingredient
Budesonide
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

Related product monographs

Document	Type	Information Source
BUDENOFALK Gastro-resistant capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
BUDENOFALK Rectal foam	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ENTOCORT CR Capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ENTOCORT Dispersible tablet and solution for rectal suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
KINPEYGO Modified-release hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.